{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:08:36Z","timestamp":1778749716152,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Education England and City Health Bradford GP Federation for financial support","award":["Reference: 0093-102021"],"award-info":[{"award-number":["Reference: 0093-102021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pharmacist roles in primary care are evolving, with increasing involvement in long-term condition management. An example is their crucial role in the management of atrial fibrillation (AF), particularly in prescribing and monitoring oral anticoagulation therapy. However, their experiences and challenges in this area remain underexplored, particularly within the context of general practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study aimed to explore the experiences, perceptions, and challenges of independent prescribing pharmacists when managing and prescribing for AF within general practice, using the Theoretical Domains Framework (TDF) to guide enquiry and analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a qualitative study underpinned by the Theoretical Domains Framework (TDF), which informed both the interview guide and the analytic coding framework. Independent prescribing pharmacists working in general practice in England were purposively recruited via professional networks; eligible participants were patient-facing and had experience prescribing for atrial fibrillation. One-to-one, semi-structured interviews were conducted via Microsoft Teams\u00ae in August 2024, audio-recorded, transcribed verbatim, and returned to participants for checking. Recruitment proceeded until thematic saturation. Two researchers independently applied the framework method, resolved discrepancies by consensus, and mapped final themes to relevant TDF domains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty pharmacists took part in the study (9 men, 11 women; age 25\u201352\u00a0years), providing perspectives from a range of experience levels. Four overarching themes emerged: (1) confidence and experience in prescribing, (2) perceived role and responsibilities, (3) barriers to effective prescribing, and (4) strategies for effective prescribing. Pharmacists with extensive AF experience demonstrated higher confidence, whereas less experienced pharmacists relied on guidelines and colleagues. Perceived roles ranged from central to supportive within multidisciplinary teams, with some uncertainty about role boundaries. Key barriers included incomplete access to patient records, limited training, and workload pressures. Strategies to support prescribing included continuous professional development, decision support tools, and peer consultation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study emphasises the challenges pharmacists encounter in managing AF, highlighting the need for clearer role definitions, improved access to patient data and ongoing peer support. Addressing the identified barriers through targeted interventions could enhance the effectiveness of pharmacist-led AF management in general practice. Future research should evaluate interventions designed to support pharmacists in this evolving role.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-025-02062-3","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T11:58:09Z","timestamp":1765367889000},"page":"740-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring pharmacist prescribing practices in general practices for atrial fibrillation in England: a qualitative study using the theoretical domains framework"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9591-4627","authenticated-orcid":false,"given":"Raman","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-2215","authenticated-orcid":false,"given":"Syed Shahzad","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-3318","authenticated-orcid":false,"given":"Barbara R.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1884-6648","authenticated-orcid":false,"given":"Muhammad Usman","family":"Ghori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"5","key":"2062_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"issue":"8","key":"2062_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study. Circulation. 2014;129(8):837\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005119.","journal-title":"Circulation"},{"key":"2062_CR3","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"F Casselman","year":"2016","unstructured":"Casselman F, Coca A, De Caterina R, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893\u2013962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210.","journal-title":"Eur Heart J"},{"key":"2062_CR4","unstructured":"National Institute for Health and Care Excellence (NICE). Atrial fibrillation: diagnosis and management. NG196. 2021. Available from: https:\/\/www.nice.org.uk\/guidance\/ng196. Accessed 2 Oct 2024."},{"key":"2062_CR5","unstructured":"NHS England. NHS England\u2019s work on stroke. Available from: https:\/\/www.england.nhs.uk\/ourwork\/clinical-policy\/stroke. Accessed 2 Oct 2024."},{"key":"2062_CR6","unstructured":"NHS England. NHS Long Term Plan: cardiovascular disease. Available from: https:\/\/www.longtermplan.nhs.uk\/areas-of-work\/cardiovascular-disease. Accessed 2 Oct 2024."},{"key":"2062_CR7","unstructured":"Barber M, Brennan K, Dennis M, et al. Scottish Stroke Improvement Programme. 2018. Available from: https:\/\/www.strokeaudit.scot.nhs.uk\/Publications\/docs\/2018-07-10-SSCA-Report.pdf. Accessed 2 Oct 2024."},{"key":"2062_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ahj.2020.07.012","volume":"229","author":"SM Al-Khatib","year":"2020","unstructured":"Al-Khatib SM, Pokorney SD, Al-Khalidi HR, et al. Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: the IMPACT-Afib trial cohort. Am Heart J. 2020;229:110\u20137. https:\/\/doi.org\/10.1016\/j.ahj.2020.07.012.","journal-title":"Am Heart J"},{"issue":"1","key":"2062_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42444-021-00053-9","volume":"23","author":"S Park","year":"2022","unstructured":"Park S, Je NK. Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants. Int J Arrhythm. 2022;23(1):1\u20138. https:\/\/doi.org\/10.1186\/s42444-021-00053-9.","journal-title":"Int J Arrhythm"},{"issue":"8","key":"2062_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.20064","volume":"4","author":"GY Lip","year":"2021","unstructured":"Lip GY, Keshishian AV, Zhang Y, et al. Oral anticoagulants for nonvalvular atrial fibrillation in patients with high risk of gastrointestinal bleeding. JAMA Netw Open. 2021;4(8):e2120064. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.20064.","journal-title":"JAMA Netw Open"},{"key":"2062_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.583311","volume":"11","author":"M Grymonprez","year":"2020","unstructured":"Grymonprez M, Steurbaut S, De Backer TL, et al. Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis. Front Pharmacol. 2020;11:583311. https:\/\/doi.org\/10.3389\/fphar.2020.583311.","journal-title":"Front Pharmacol"},{"issue":"4","key":"2062_CR12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.sapharm.2018.06.001","volume":"15","author":"C Anderson","year":"2019","unstructured":"Anderson C, Zhan K, Boyd M, et al. The role of pharmacists in general practice: a realist review. Res Social Adm Pharm. 2019;15(4):338\u201345. https:\/\/doi.org\/10.1016\/j.sapharm.2018.06.001.","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"2062_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13827","volume":"75","author":"T Mills","year":"2021","unstructured":"Mills T, Patel N, Ryan K. Pharmacist non-medical prescribing in primary care: a systematic review of views, opinions and attitudes. Int J Clin Pract. 2021;75(3):e13827. https:\/\/doi.org\/10.1111\/ijcp.13827.","journal-title":"Int J Clin Pract"},{"key":"2062_CR14","unstructured":"NHS England. NHS long term workforce plan. London: NHS England; 2023. Available from: https:\/\/www.england.nhs.uk\/publication\/nhs-long-term-workforce-plan\/. Accessed 2 Oct 2024."},{"key":"2062_CR15","unstructured":"NHS England, British Medical Association. Investment and evolution: a five-year framework for GP contract reform to implement the NHS Long Term Plan. 2019. Available from: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/01\/gp-contract-2019.pdf. Accessed 2 Oct 2024."},{"key":"2062_CR16","unstructured":"NHS Digital. Primary Care Network workforce, 30 June 2024. 2024. Available from: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/primary-care-network-workforce\/30-june-2024. Accessed 2 Oct 2024."},{"key":"2062_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-022-00483-3","author":"E Chopra","year":"2022","unstructured":"Chopra E, Choudhary T, Hazen A, et al. Clinical pharmacists in primary care general practices: evaluation of current workforce and their distribution. J Pharm Policy Pract. 2022. https:\/\/doi.org\/10.1186\/s40545-022-00483-3.","journal-title":"J Pharm Policy Pract"},{"key":"2062_CR18","doi-asserted-by":"publisher","DOI":"10.2147\/IPRP.S397844","author":"EL Veale","year":"2024","unstructured":"Veale EL. Pharmacy-led management of atrial fibrillation: improving treatment adherence and patient outcomes. Integr Pharm Res Pract. 2024. https:\/\/doi.org\/10.2147\/IPRP.S397844.","journal-title":"Integr Pharm Res Pract"},{"issue":"6","key":"2062_CR19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ijpp.12426","volume":"26","author":"J Bush","year":"2018","unstructured":"Bush J, Langley CA, Jenkins D, et al. Clinical pharmacists in general practice: an initial evaluation of activity in one English primary care organisation. Int J Pharm Pract. 2018;26(6):501\u20136. https:\/\/doi.org\/10.1111\/ijpp.12426.","journal-title":"Int J Pharm Pract"},{"key":"2062_CR20","unstructured":"NHS England. Network Contract Directed Enhanced Service: structured medication reviews and medicines optimisation \u2013 guidance. 2020. Available from: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2020\/09\/SMR-Spec-Guidance-2020-21-FINAL-.pdf. Accessed 2 Oct 2024."},{"key":"2062_CR21","doi-asserted-by":"publisher","DOI":"10.3399\/BJGPO.2023.0113","author":"R Sharma","year":"2024","unstructured":"Sharma R, Hasan SS, Gilkar IA, et al. Pharmacist-led interventions in optimising the use of oral anticoagulants in patients with atrial fibrillation in general practice in England: a retrospective observational study. BJGP Open. 2024. https:\/\/doi.org\/10.3399\/BJGPO.2023.0113.","journal-title":"BJGP Open"},{"issue":"6","key":"2062_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/ehjqcco\/qcae045","volume":"10","author":"B Kefale","year":"2024","unstructured":"Kefale B, Peterson GM, Mirkazemi C, et al. The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis. Euro Heart J Quality Care Clin Outcomes. 2024;10(6):488\u2013506. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae045.","journal-title":"Euro Heart J Quality Care Clin Outcomes"},{"issue":"1","key":"2062_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-022-00486-0","volume":"15","author":"S Al-Arkee","year":"2022","unstructured":"Al-Arkee S, Mason J, Lindenmeyer A, et al. Pharmacist management of atrial fibrillation in UK primary care: a qualitative study. J Pharm Policy Pract. 2022;15(1):98. https:\/\/doi.org\/10.1186\/s40545-022-00486-0.","journal-title":"J Pharm Policy Pract"},{"key":"2062_CR24","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101042","author":"V Savickas","year":"2020","unstructured":"Savickas V, Veale EL, Bhamra SK, et al. Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study. BJGP Open. 2020. https:\/\/doi.org\/10.3399\/bjgpopen20X101042.","journal-title":"BJGP Open"},{"issue":"4","key":"2062_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jac5.1593","volume":"5","author":"AN Hemenway","year":"2022","unstructured":"Hemenway AN, Meyer-Junco L, Zobeck B, et al. Utilizing social and behavioral change methods in clinical pharmacy initiatives. J Am Coll Clin Pharm. 2022;5(4):450\u20138.","journal-title":"J Am Coll Clin Pharm"},{"issue":"8","key":"2062_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.sapharm.2023.05.006","volume":"19","author":"N Jamil","year":"2023","unstructured":"Jamil N, Zainal ZA, Alias SH, et al. A systematic review of behaviour change techniques in pharmacist-delivered self-management interventions towards patients with chronic obstructive pulmonary disease. Res Social Adm Pharm. 2023;19(8):1131\u201345. https:\/\/doi.org\/10.1016\/j.sapharm.2023.05.006.","journal-title":"Res Social Adm Pharm"},{"key":"2062_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2061","volume":"374","author":"K Skivington","year":"2021","unstructured":"Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. Br Med J. 2021;374:n2061. https:\/\/doi.org\/10.1136\/bmj.n2061.","journal-title":"Br Med J"},{"key":"2062_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-015-0280-7","volume":"10","author":"EA Little","year":"2015","unstructured":"Little EA, Presseau J, Eccles MP. Understanding effects in reviews of implementation interventions using the theoretical domains framework. Implement Sci. 2015;10:90. https:\/\/doi.org\/10.1186\/s13012-015-0280-7.","journal-title":"Implement Sci"},{"issue":"6","key":"2062_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"2062_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12874-018-0594-7","volume":"18","author":"K Vasileiou","year":"2018","unstructured":"Vasileiou K, Barnett J, Thorpe S, et al. Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period. BMC Med Res Methodol. 2018;18:148. https:\/\/doi.org\/10.1186\/s12874-018-0594-7.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"2062_CR31","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/08870440903194015","volume":"25","author":"JJ Francis","year":"2010","unstructured":"Francis JJ, Johnston M, Robertson C, et al. What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health. 2010;25(10):1229\u201345. https:\/\/doi.org\/10.1080\/08870440903194015.","journal-title":"Psychol Health"},{"key":"2062_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-35","volume":"7","author":"JJ Francis","year":"2012","unstructured":"Francis JJ, O\u2019Connor D, Curran J. Theories of behaviour change synthesised into a set of theoretical groupings: introducing a thematic series on the theoretical domains framework. Implement Sci. 2012;7:35. https:\/\/doi.org\/10.1186\/1748-5908-7-35.","journal-title":"Implement Sci"},{"key":"2062_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-017-0605-9","volume":"12","author":"L Atkins","year":"2017","unstructured":"Atkins L, Francis J, Islam R, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12:77. https:\/\/doi.org\/10.1186\/s13012-017-0605-9.","journal-title":"Implement Sci"},{"issue":"2","key":"2062_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/EFI-2004-22201","volume":"22","author":"AK Shenton","year":"2004","unstructured":"Shenton AK. Strategies for ensuring trustworthiness in qualitative research projects. Educ Inf. 2004;22(2):63\u201375. https:\/\/doi.org\/10.3233\/EFI-2004-22201.","journal-title":"Educ Inf"},{"issue":"12","key":"2062_CR35","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.amjmed.2022.07.014","volume":"135","author":"LA Ritchie","year":"2022","unstructured":"Ritchie LA, Penson PE, Akpan A, et al. Integrated care for atrial fibrillation management: the role of the pharmacist. Am J Med. 2022;135(12):1410\u201326. https:\/\/doi.org\/10.1016\/j.amjmed.2022.07.014.","journal-title":"Am J Med"},{"issue":"4","key":"2062_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.sapharm.2013.08.006","volume":"10","author":"EC Tan","year":"2014","unstructured":"Tan EC, Stewart K, Elliott RA, et al. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10(4):608\u201322. https:\/\/doi.org\/10.1016\/j.sapharm.2013.08.006.","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"2062_CR37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/13561820500053454","volume":"19","author":"A Shaw","year":"2005","unstructured":"Shaw A, de Lusignan S, Rowlands G. Do primary care professionals work as a team? A qualitative study. J Interprof Care. 2005;19(4):396\u2013405. https:\/\/doi.org\/10.1080\/13561820500053454.","journal-title":"J Interprof Care"},{"issue":"12","key":"2062_CR38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/thorax-2023-220387","volume":"78","author":"N Leggett","year":"2023","unstructured":"Leggett N, Emery K, Rollinson TC, et al. Fragmentation of care between intensive and primary care settings and opportunities for improvement. Thorax. 2023;78(12):1181\u20137. https:\/\/doi.org\/10.1136\/thorax-2023-220387.","journal-title":"Thorax"},{"issue":"6","key":"2062_CR39","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1002\/nop2.1607","volume":"10","author":"JY Joo","year":"2023","unstructured":"Joo JY. Fragmented care and chronic illness patient outcomes: a systematic review. Nurs Open. 2023;10(6):3460\u201373. https:\/\/doi.org\/10.1002\/nop2.1607.","journal-title":"Nurs Open"},{"issue":"2","key":"2062_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/20534345211004503","volume":"24","author":"L Davidson","year":"2021","unstructured":"Davidson L, Scott J, Forster N. Patient experiences of integrated care within the United Kingdom: a systematic review. Int J Care Coord. 2021;24(2):39\u201356. https:\/\/doi.org\/10.1177\/20534345211004503.","journal-title":"Int J Care Coord"},{"issue":"10035","key":"2062_CR41","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/S0140-6736(16)00620-6","volume":"387","author":"FDR Hobbs","year":"2016","unstructured":"Hobbs FDR, Bankhead C, Mukhtar T, et al. Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007\u201314. Lancet. 2016;387(10035):2323\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(16)00620-6.","journal-title":"Lancet"},{"key":"2062_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-016-0396-4","volume":"11","author":"R Lau","year":"2016","unstructured":"Lau R, Stevenson F, Ong BN, et al. Achieving change in primary care\u2014causes of the evidence to practice gap: systematic reviews of reviews. Implement Sci. 2016;11:40. https:\/\/doi.org\/10.1186\/s13012-016-0396-4.","journal-title":"Implement Sci"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02062-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-02062-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02062-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:16:22Z","timestamp":1778746582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-02062-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2062"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-02062-3","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the School of Applied Sciences Research Integrity and Ethics Committee, University of Huddersfield (reference: SAS-SRIEC-06.08.24\u20131; approved 06 August 2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants prior to the interviews.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}